Skip to main content
. 2018 Jan;26(1):43–53. doi: 10.1016/j.joca.2017.09.010

Table III.

Self-report quality indicators of osteoarthritis care and treatment used within the first 6 months of consultation

Self-reported OA quality indicators Intervention Control OR (95% CI) Absolute % differenceΔ (95% CI) P-value
Treatment offered
‡Education, advice and access to information 95.0% 91.5% 2.95 (0.68, 12.8) 5.4% (−3.5%, 7.7%) 0.148
Support on how to help self with joint problem 66.9% 60.1% 1.91 (0.95, 3.81) 14.1% (−1.1%, 25.1%) 0.068
Information/advice about exercises, muscle strengthening or physical activities 81.5% 63.3% 3.01 (1.43, 6.32) 20.5% (7.9%, 28.3%) 0.004
Referral to strengthening or physical activities 54.4% 46.9% 1.45 (0.85, 2.55) 9.2% (−3.9%, 22.3%) 0.126
#Advice to lose weight 46.3% 43.0% 1.33 (0.79, 2.24) 7.0% (−5.7%, 19.8%) 0.288
#Referral to services for losing weight 16.4% 12.9% 2.92 (0.85, 9.98) 17.3% (−1.7%, 46.7%) 0.087
Paracetamol recommended for pain 79.7% 70.3% 1.80 (1.03, 4.25) 10.7% (0.6%, 20.7%) 0.037
Stronger painkiller 69.4% 68.8% 1.18 (0.71, 1.95) 3.4% (−7.8%, 12.3%) 0.529
Information about drugs effect provided 68.2% 72.6% 0.65 (0.39, 1.09) −9.2% (−21.6%, 1.6%) 0.101
Corticosteroid joint injection 35.2% 35.8% 1.12 (0.64, 1.84) 2.6% (−9.6%, 14.8%) 0.677
Surgery evaluation 32.3% 37.0% 0.82 (0.42, 1.62) −4.4% (−17.3%, 11.8%) 0.574
Need for walking aid assessed 28.9% 28.9% 1.05 (0.60, 1.65) 1.0% (−9.3%, 11.3%) 0.853
Need for appliances/aids to daily living 14.4% 18.2% 0.91 (0.45, 1.82) −1.4% (−9.1%, 10.6%) 0.780
Treatment used
‡Education, advice and access to information 62.0% 47.6% 2.67 (1.62, 4.40) 23.2% (11.9%, 32.4%) <0.001
Muscle strengthening exercises 60.5% 44.3% 1.91 (1.20, 3.20) 16.0% (4.4%, 27.5%) 0.007
General fitness exercises 38.0% 35.4% 0.80 (0.45, 1.29) −4.8% (−15.6%, 6.0%) 0.384
Physiotherapy 40.1% 38.6% 0.65 (0.38, 1.13) −9.5% (−19.4%, 2.9%) 0.126
#Dieting to lose weight 48.4% 50.9% 0.87 (0.52, 1.44) −3.6% (−16.0%, 8.9%) 0.577
Paracetamol 86.5% 84.8% 1.24 (0.63, 2.44) 2.6% (−7.0%, 8.4%) 0.535
Anti-inflammatory creams/gels e.g., topical NSAIDs 81.6% 79.8% 1.21 (0.67, 2.21) 2.9% (−7.3%, 9.9%) 0.527
Capsaicin cream 21.8% 19.4% 1.55 (0.87, 2.77) 7.7% (−2.2%, 20.6%) 0.141
Anti-inflammatory tablets, e.g., oral NSAIDs 59.9% 70.6% 0.51 (0.31, 0.85) −15.6% (−28.3%, −3.5%) 0.010
Stronger painkillers, e.g., Opioids 62.9% 62.6% 1.12 (0.70, 1.80) 2.7% (−8.6%, 12.5%) 0.626
Community pharmacy 25.8% 16.5% 1.84 (1.02, 3.34) 10.2% (0.3%, 23.3%) 0.043
Walking aids 41.9% 50.4% 0.57 (0.34, 0.94) −13.9% (−24.6%, −1.6%) 0.027
Shock-absorbing shoes or insoles 34.8% 31.8% 1.34 (0.81, 2.21) 6.6% (−4.5%, 18.9%) 0.259
Appliances and support and braces 33.0% 36.9% 0.78 (0.44, 1.25) −5.5% (−16.3%, 5.4%) 0.321
Assistive devices 25.1% 25.2% 1.35 (0.81, 2.07) 6.1% (−3.7%, 15.9%) 0.222
Transcutaneous electric nerve stimulation (TENS) 16.2% 16.4% 0.98 (0.52, 1.82) −0.3% (−7.1%, 9.9%) 0.944
Warmth, heat or cold application 61.2% 58.4% 1.10 (0.69, 1.75) 2.3% (−9.1%, 12.7%) 0.688

Results were derived through multiple imputation of missing data using chained equations with mixed models for estimating coefficients (hence, denominator population n = 525; except for # which included 390 participants classified as clinically overweight or obese (classified as having a BMI ≥ 25 kg m−2)).

Δ Absolute percent differences were calculated by applying odds ratios derived by logistic mixed regression adjusted for age, sex and practice size to percent figures for the reference (control group) (clustering by GP practice accounted for in the mixed model). % difference relates to % in intervention group – % in control group.

‡ Comprises written or verbal information about joint problem, information about treatments and advice on self-management of joint problem.